Today: 3 March 2026
Browse Category

Stock Market 6 October 2025 - 7 October 2025

Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough – Inside the Stock Surge, Pipeline & Outlook (Oct 2025)

Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough – Inside the Stock Surge, Pipeline & Outlook (Oct 2025)

Spruce Biosciences shares soared over 1,300% after the FDA granted breakthrough therapy designation to its lead drug for Sanfilippo Syndrome Type B. Trading was repeatedly halted amid a flood of investor interest, including public backing from Martin Shkreli. The company, recently relisted on Nasdaq, faces ongoing financial strain with just $16.4 million in cash and no significant revenue.
Galecto Stock Skyrockets 600% – Short Squeeze Mania or Biotech Breakthrough?

Galecto Stock Skyrockets 600% – Short Squeeze Mania or Biotech Breakthrough?

Galecto Inc. (NASDAQ: GLTO) shares soared over 600% in pre-market trading on Oct. 7, 2025, with more than 42 million shares traded despite no new company news. The stock, previously a low-float penny biotech, briefly touched $10 before retreating. Galecto has no revenue, heavy losses, and ended Q2 with $10.2 million in cash. Analysts remain cautious, citing high financial risk and limited coverage.
7 October 2025
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD’s Stock Skyrockets After Blockbuster OpenAI Deal – What It Means for Investors in 2025

AMD shares jumped about 30% in early October 2025 after announcing a multi-year deal to supply AI chips to OpenAI, sending the stock near $200 and market value above $300 billion. OpenAI received warrants to buy up to 10% of AMD’s stock at $0.01 per share. Major tech firms are already testing AMD’s new AI chips. Analysts raised price targets, with Jefferies setting a Street-high $300 after the deal.
Nvidia’s Meteoric October: $4 Trillion Milestone, Mega AI Deals, and Unstoppable Momentum

Nvidia’s $4 Trillion AI Juggernaut: Record Stock Surge, Mega Deals & What’s Next for NVDA

Nvidia’s stock hit a record high in October 2025, briefly surpassing a $4 trillion market cap and overtaking Apple and Microsoft. Quarterly revenue jumped 56% to $46.7 billion, driven by soaring AI chip demand. The company announced a $100 billion partnership with OpenAI and took a $5 billion stake in Intel. AMD’s new deal with OpenAI sent its shares up 24%, while Nvidia’s slipped 1% on competitive concerns.
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Tesla’s October Surprise: Stock Soars on Record Sales, ‘Secret’ Model Y Reveal & Musk’s Next Move

Tesla stock jumped over 5% to $453 on Oct. 6, 2025, buoyed by record Q3 deliveries of 497,099 vehicles, far above Wall Street estimates. The surge followed a teaser for an Oct. 7 product reveal, widely expected to be a cheaper Model Y. Tesla’s market cap stands at $1.5 trillion. Analysts remain split, with the average price target well below current levels.
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Gold Rush: D-Wave (QBTS) Stock Skyrockets 3000% – Hype or Game-Changer?

D-Wave Quantum (NYSE: QBTS) shares closed at $32.70 on Oct. 3, up 12% for the day and over 3,000% year-on-year, lifting its market cap to around $10–11 billion. Q2 2025 revenue reached $3.1 million, but the company posted a $167 million net loss. D-Wave ended the quarter with $819 million in cash after a $400 million stock offering. Recent pilot projects and partnerships have driven investor enthusiasm.
IonQ’s 2025 Quantum Leap: Surging Stock, Bold Ambitions & How It Compares to Rigetti and D-Wave

Quantum Boom: IonQ Stock Skyrockets to Record High on Breakthroughs & Bold Ambitions

IonQ shares hit a record high near $75 in early October, up over 700% year-on-year, pushing its market value to about $22 billion. The company reported Q2 revenue of $20.7 million but posted a $177.5 million net loss. IonQ raised $1 billion in new capital and acquired Oxford Ionics for $1.08 billion. Technical breakthroughs and new deals, including a stake in Einride, fueled the rally.
OPEC’s Surprise Output Hike Leaves Oil Prices Steady – But Glut Fears Loom

OPEC’s Surprise Output Hike Leaves Oil Prices Steady – But Glut Fears Loom

OPEC+ agreed on Oct. 5, 2025, to raise crude output by 137,000 barrels per day in November, matching October’s increase. Brent crude held near $65.5 per barrel after the announcement, while U.S. WTI hovered around $61.7. The decision followed internal disputes, with Russia favoring a smaller hike and Saudi Arabia pushing for more. Analysts warn of a potential oil surplus by late 2025 as supply rises and demand growth slows.
7 October 2025
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Nasdaq Futures Slip After AI-Fueled Record Rally – Fed Cuts, Shutdown Drama & Tech Frenzy Drive Wall Street Surge

The S&P 500 and Nasdaq closed at record highs Monday, driven by AMD’s 23.7% surge after announcing an AI chip partnership with OpenAI. U.S. stock futures slipped early Tuesday as the government shutdown delayed key economic data, pushing investors to watch Fed commentary for signals on rates. Futures markets now see a 95% chance of a Fed rate cut in October. Tesla, AppLovin, and Robinhood also posted strong gains on tech optimism.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

AI Frenzy Fuels Record Wall St Rally as Shutdown Drags On – Key Market News (Oct 6-7, 2025)

The S&P 500 and Nasdaq closed at record highs Monday, while the Dow edged lower. AMD soared 24% after announcing an AI chip deal with OpenAI, boosting the semiconductor sector. Bitcoin hit a new record above $125,000. AppLovin plunged 14% on news of an SEC probe; Comerica jumped after a takeover deal.
Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir’s AI-Fueled Surge Faces Army Security Scare – October 2025 Stock Report

Palantir Technologies shares have surged over 130% year-to-date in 2025, following record Q2 revenue of $1 billion and raised full-year guidance. The company secured a $10 billion U.S. Army deal and a £1.5 billion U.K. defense contract. A leaked Army memo on security flaws briefly sent shares down 7.5%, but reassurances helped the stock rebound 3% by October 6. Palantir also signed a major healthcare AI partnership with OneMedNet.
Cavco Industries’ Rollercoaster: Record Highs, Big Acquisition & Housing Market Headwinds (Oct 2025 Update)

Cavco Industries’ Rollercoaster: Record Highs, Big Acquisition & Housing Market Headwinds (Oct 2025 Update)

Cavco Industries shares hit a 52-week high of $574.20 in late September before plunging 12.6% on October 6 to close near $498.60. The drop followed strong Q1 FY2026 results, with revenue up 16.6% to $557 million and EPS rising 56% to $6.42. Cavco completed a $190 million cash acquisition of American Homestar in late September. The stock remained up about 30% year-to-date despite the volatility.
7 October 2025
Quantum Computing Inc. (QUBT): 2025’s Wild 3,200% Quantum Stock Surge – Boom or Bubble?

Quantum Computing Inc (QUBT) Skyrockets 2,500%: $750 M Windfall, Quantum Breakthroughs & Bubble Fears

Quantum Computing Inc. (NASDAQ: QUBT) surged over 2,500% year-on-year, closing at $24.62 on Oct. 3 after a 23% jump. The company raised $750 million in late September, boosting its cash reserves but diluting shareholders. QUBT launched a room-temperature quantum encryption network and secured contracts with NASA and a major bank. Trading remains volatile; the firm’s $4–5 billion market cap contrasts with just $61,000 in Q2 revenue.
Opendoor’s Wild 2025 Ride: 1600% Stock Surge, Crypto Moves, and a Real Estate Rebound – What’s Next for OPEN?

Opendoor’s Wild 2025 Ride: 1600% Stock Surge, Crypto Moves, and a Real Estate Rebound – What’s Next for OPEN?

Opendoor shares soared from under $1 in June to over $10 by mid-September 2025, then settled near $8–9 after volatile trading and a leadership shake-up. CEO Carrie Wheeler resigned in August; Kazimier Nejatian took over in September, with co-founder Keith Rabois returning as chairman and signaling deep job cuts. Q2 2025 saw $1.6 billion revenue and positive adjusted EBITDA, but net loss narrowed to $29 million. Crypto payment plans sparked a 14% stock jump in October.
Applied Digital (APLD) Skyrockets on AI Deals – Is the Rally Sustainable?

Forward Industries’ Wild Crypto Pivot: $4B Solana Bet, 500% Stock Surge & Wall Street Skepticism

Forward Industries closed at $25.43 on October 6, 2025, up over 400% year-to-date after pivoting from carrying cases to a Solana crypto treasury. The company raised $1.65 billion, bought 6.82 million SOL, and filed for a $4 billion stock offering. Shares hit $46 in September before dropping. Analysts have downgraded the stock, citing poor fundamentals and a recent net loss.
Eightco Holdings (ORBS) Rides Wild Worldcoin Wave – 34% Stock Spike Caps Frenzied Month

Eightco Holdings (ORBS) Rides Wild Worldcoin Wave – 34% Stock Spike Caps Frenzied Month

Eightco Holdings shares jumped 34% to $11.07 on October 6, reversing a recent slide and ranking among Nasdaq’s top gainers. The stock remains volatile after a 3,000% surge in September, driven by a $250 million Worldcoin treasury bet and a new chairman. Verified Worldcoin users surpassed 17 million, while options trading on ORBS began in early October. The company trades at 40–50× sales and remains unprofitable.
AppLovin (APP) Stock Report: S&P 500 Boost to SEC Scrutiny

AppLovin (APP) Stock Report: S&P 500 Boost to SEC Scrutiny

AppLovin shares jumped about 520% year-to-date, peaking near $720 in September 2025 before retreating after news of an SEC probe into its data practices. Q2 revenue rose 77% to $1.26 billion with net income at $819 million. The stock’s market cap hit $230 billion at its high. Trading volume spiked, with 12.9 million shares changing hands on Oct. 6 after the SEC news.
6 October 2025
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Skyrockets on ACA Hopes and Tech-Driven Growth – Can the Insurtech Finally Turn a Profit?

Oscar Health closed at $22.30 on Oct. 6, 2025, with a market cap near $5.6 billion after surging 42% year-to-date. Q2 revenue rose 29% to $2.86 billion, but the company posted a $228 million net loss as its medical loss ratio jumped to 91.1%. Membership topped 2 million. Wall Street consensus remains “Strong Sell,” with an average 12-month price target of $12.
6 October 2025
Oklo (OKLO) Nuclear Stock Skyrockets 500% on AI Data Center Hype – Bubble or Breakthrough?

Nuclear Renaissance: How Oklo’s DOE Contracts and Fuel‑Recycling Ambitions Triggered a 1,200 % Rally – But Can the 2025 Hype Last?

Oklo stock (NYSE: OKLO) surged over 500% year-to-date in 2025, reaching a record $146.40 intraday high in October. The U.S. Department of Energy selected Oklo for two pilot programs, fast-tracking its reactor projects. Despite the rally, Oklo remains pre-revenue and posted a Q2 net loss of $0.18 per share. Major banks downgraded the stock, and insiders sold shares amid stretched valuations.
6 October 2025
Astera Labs Stock Soars on AI Momentum: Is This High-Flying Chip Innovator Still a Buy in 2025?

Astera Labs Stock Explodes Over 200% — But Is the AI Connectivity Darling Priced for Perfection?

Astera Labs shares surged over 220% in six months, reaching a $33 billion market value and closing at $229 on Oct. 6 after a 14% rally. Fiscal Q2 2025 revenue jumped 150% to $191.9 million, with non-GAAP EPS at $0.44 and $1.07 billion in cash. The stock trades at over 300 times trailing earnings. Analysts’ average 12-month price target is $160, below current levels.
Go toTop